The efficacy and safety of antibodies targeting PD-1 for treatment in advanced esophageal cancer: A systematic review and meta-analysis
Background: A novel therapy based on programmed death 1 (PD-1) inhibitors has been proved to be effective in advanced esophageal cancer. This article is a meta-analysis that aims to compare the efficacy and safety of anti-PD-1 therapy with chemotherapy in esophageal cancer. Patients and methods: Dat...
Main Authors: | Yao Lu, Lulu Guan, Mengli Xu, Feng Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | Translational Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523321000759 |
Similar Items
-
Comparative Impact of PD-1 and PD-L1 Inhibitors on Advanced Esophageal or Gastric/Gastroesophageal Junction Cancer Treatment: A Systematic Review and Meta-Analysis
by: SuA Oh, et al.
Published: (2021-08-01) -
A Systematic Review and Meta-Analysis Assessing the Relative Efficacy of Immune Checkpoint Inhibitors Based on PD-L1 Expression Levels
by: Kwiatkowski, Kathy
Published: (2020) -
A meta-analysis of the efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors as treatments for metastatic bladder cancer
by: Fan Z, et al.
Published: (2019-03-01) -
Anti‐PD1 versus anti‐PD‐L1 immunotherapy in first‐line therapy for advanced non‐small cell lung cancer: A systematic review and meta‐analysis
by: Angelo Borsarelli Carvalho Brito, et al.
Published: (2021-04-01) -
Role of surgery in multidisciplinary treatment strategies for locally advanced esophageal squamous cell carcinoma
by: Hiroshi Saeki, et al.
Published: (2020-09-01)